UNSPSC 51101694: Tosulur

This classification denotes an antiprotozoal agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I04MF82GW9. European Medicines Agency schedules Tosulur in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11202MIG. Tosulur generally arises in the molecular formula C11H15NO5S.

The term TOSULUR is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, no. 6, 1984, list 24.) TOSULUR is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tosulur under HS 29350090 and SITC 51580. As of Q4 2014, TOSULUR remains the US FDA Preferred Term for this commodity. Tosulur bears US NLM identifiers UMLS ID C2699972 and NCI Concept Code C76434. SMILES: CC1=CC=C(C=C1)S(=O)(=O)NC(=O)OCCOC.

UNSPSC 51101694 Tosulur is a Commodity code under which state and local governments procure naloxone, pharmaceutical products, medical and first aid supplies, and over-the-counter medications for public health, emergency response, and benefit program administration. Recent solicitations show purchasing bodies acquiring naloxone units and drug deactivation systems for community health initiatives, generic pharmaceuticals and OTC products through cooperative purchasing alliances, and medical consumables including respiratory equipment, cardiac monitoring devices, and bandaging materials for fire department rescue operations. The issuing bodies span county health departments, state human services commissions, municipal fire departments, and multi-state purchasing cooperatives. Geographic activity includes Florida, Texas, Minnesota, and Oregon, with representation across both single-jurisdiction and multi-state cooperative procurement vehicles.

Recent representative opportunities include Seminole County, Florida's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building (response deadline July 26, 2023); the City of Tampa's IFB for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract amount of $700,000.00 and a sheltered-market set-aside for certified Small Local Business Enterprises offering a 5 percent bid discount not to exceed $10,000 (due March 13, 2026); the Texas Health and Human Services Commission's RFI soliciting vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program (due April 3, 2026); and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities, with proposals due March 26, 2026 and contract effectiveness of July 1, 2026. The MMCAP procurement requires vendors to supply through three authorized wholesalers and comply with current Good Manufacturing Practices and Drug Supply Chain Security Act certification, with a 3 percent administrative fee on all contract purchases.